[HTML][HTML] Tumor suppressors having oncogenic functions: the double agents

N Datta, S Chakraborty, M Basu, MK Ghosh - Cells, 2020 - mdpi.com
Cancer progression involves multiple genetic and epigenetic events, which involve gain-of-
functions of oncogenes and loss-of-functions of tumor suppressor genes. Classical tumor …

[HTML][HTML] Therapeutic targeting of CK2 in acute and chronic leukemias

F Buontempo, JA McCubrey, E Orsini, M Ruzzene… - Leukemia, 2018 - nature.com
CK2 is a ubiquitously expressed, constitutively active Ser/Thr protein kinase, which is
considered the most pleiotropic protein kinase in the human kinome. Such a pleiotropy …

[HTML][HTML] Targeting mTOR in acute lymphoblastic leukemia

C Simioni, AM Martelli, G Zauli, E Melloni, LM Neri - Cells, 2019 - mdpi.com
Acute Lymphoblastic Leukemia (ALL) is an aggressive hematologic disorder and constitutes
approximately 25% of cancer diagnoses among children and teenagers. Pediatric patients …

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia

C Song, C Gowda, X Pan, Y Ding… - Blood, The Journal …, 2015 - ashpublications.org
Ikaros (IKZF1) is a tumor suppressor that binds DNA and regulates expression of its target
genes. The mechanism of Ikaros activity as a tumor suppressor and the regulation of Ikaros …

MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology

HS Chawra, M Agarwal, A Mishra, SS Chandel… - … -Research and Practice, 2024 - Elsevier
Abstract MicroRNA-21 (miR-21) was recognized as a key figure in the intricate web of tumor
biology, with a prominent role in regulating the PTEN tumor suppressor gene and the …

Kinases, tails and more: regulation of PTEN function by phosphorylation

R Fragoso, JT Barata - Methods, 2015 - Elsevier
Phosphorylation regulates the conformation, stability, homo-and heterotypic protein
interactions, localization, and activity of the tumor suppressor PTEN. From a simple picture …

[HTML][HTML] Targeting protein kinases in blood cancer: focusing on CK1α and CK2

Z Spinello, A Fregnani, L Quotti Tubi, L Trentin… - International journal of …, 2021 - mdpi.com
Disturbance of protein kinase activity may result in dramatic consequences that often lead to
cancer development and progression. In tumors of blood origin, both tyrosine kinases and …

[HTML][HTML] Cancer-type dependent expression of CK2 transcripts

MMJ Chua, M Lee, I Dominguez - PloS one, 2017 - journals.plos.org
A multitude of proteins are aberrantly expressed in cancer cells, including the oncogenic
serine-threonine kinase CK2. In a previous report, we found increases in CK2 transcript …

PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism

N Li, J Qin, L Lan, H Zhang, F Liu, Z Wu… - Cancer biology & …, 2015 - Taylor & Francis
PTEN has been studied in several tumor models as a tumor suppressor. In this study, we
explored the role of PTEN in the inhibition state of polarized M2 subtype of macrophage in …

[HTML][HTML] The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia

RD Mendes, K Canté-Barrett, R Pieters… - …, 2016 - ncbi.nlm.nih.gov
The tumor suppressor phosphatase and tensin homolog (PTEN) negatively regulates
phosphatidylinositol 3-kinase (PI3K)-AKT signaling and is often inactivated by mutations …